Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Cardio Diagnostics Holdings (CDIO) FCF Margin (2022 - 2025)

Cardio Diagnostics Holdings' FCF Margin history spans 4 years, with the latest figure at 54509.7% for Q3 2025.

  • For Q3 2025, FCF Margin fell 3656738.0% year-over-year to 54509.7%; the TTM value through Sep 2025 reached 37689.99%, down 2078048.0%, while the annual FY2024 figure was 14926.54%, 2168546.0% up from the prior year.
  • FCF Margin for Q3 2025 was 54509.7% at Cardio Diagnostics Holdings, down from 21273.06% in the prior quarter.
  • Across five years, FCF Margin topped out at 7866.87% in Q1 2024 and bottomed at 348309.37% in Q4 2022.
  • The 4-year median for FCF Margin is 30938.23% (2024), against an average of 69123.98%.
  • The largest annual shift saw FCF Margin surged 30645005bps in 2023 before it plummeted -14169568bps in 2025.
  • A 4-year view of FCF Margin shows it stood at 348309.37% in 2022, then skyrocketed by 88bps to 41859.32% in 2023, then increased by 26bps to 30938.23% in 2024, then crashed by -76bps to 54509.7% in 2025.
  • Per Business Quant, the three most recent readings for CDIO's FCF Margin are 54509.7% (Q3 2025), 21273.06% (Q2 2025), and 149562.55% (Q1 2025).